MARSHALL WACE ASIA Ltd bought a new stake in shares of Aetna Inc. (NYSE:AET) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 126,857 shares of the company’s stock, valued at approximately $16,237,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AET. Independent Advisor Alliance bought a new position in shares of Aetna during the fourth quarter worth $415,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in shares of Aetna during the fourth quarter worth $105,286,000. Capital Guardian Trust Co. increased its position in shares of Aetna by 6.2% in the fourth quarter. Capital Guardian Trust Co. now owns 698,165 shares of the company’s stock worth $86,579,000 after buying an additional 40,712 shares during the last quarter. Armistice Capital LLC bought a new position in Aetna during the fourth quarter valued at approximately $7,937,000. Finally, CAMG Solamere Management LLC bought a new position in Aetna during the fourth quarter valued at approximately $1,822,000. 91.80% of the stock is currently owned by institutional investors and hedge funds.
Aetna Inc. (NYSE:AET) traded up 0.90% on Friday, hitting $155.29. The stock had a trading volume of 1,697,272 shares. The company has a 50-day moving average price of $152.90 and a 200-day moving average price of $136.75. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $157.55. The stock has a market capitalization of $51.51 billion, a price-to-earnings ratio of 47.36 and a beta of 0.54.
Aetna (NYSE:AET) last released its earnings results on Tuesday, May 2nd. The company reported $2.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.36 by $0.35. The company had revenue of $15.17 billion during the quarter, compared to the consensus estimate of $15.39 billion. Aetna had a return on equity of 17.75% and a net margin of 1.84%. Aetna’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.30 EPS. Equities analysts predict that Aetna Inc. will post $8.99 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were given a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.29%. Aetna’s payout ratio is 62.31%.
COPYRIGHT VIOLATION NOTICE: “126,857 Shares in Aetna Inc. (NYSE:AET) Acquired by MARSHALL WACE ASIA Ltd” was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2017/07/30/marshall-wace-asia-ltd-invests-16-24-million-in-aetna-inc-nyseaet-updated-updated-updated.html.
AET has been the subject of a number of recent research reports. CIBC reissued an “outperform” rating on shares of Aetna in a research report on Monday, April 3rd. Royal Bank Of Canada reaffirmed a “buy” rating and set a $145.00 price objective on shares of Aetna in a research report on Monday, April 24th. Bank of America Corporation reaffirmed a “buy” rating and set a $168.00 price objective (up previously from $160.00) on shares of Aetna in a research report on Wednesday, May 17th. Morgan Stanley assumed coverage on shares of Aetna in a research report on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price objective for the company. Finally, Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a research report on Tuesday, July 4th. Seven analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $152.84.
In other Aetna news, Chairman Mark T. Bertolini sold 103,547 shares of Aetna stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares of the company’s stock, valued at approximately $92,905,631.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.